Integrated stability and metabolomic investigation of new rifampicin and isoniazid co-loaded liposome against tuberculosis
The co-loaded RIF-INH liposomal system offers a promising, clinically translatable approach for sustained drug release and improved tuberculosis therapy.
Authors
- Vinod L. Gaikwad (ORCID: https://orcid.org/0000-0002-3368-4467)
- Rahul L. Gajbhiye (ORCID: https://orcid.org/0000-0003-0490-1423)
- Ramalingam Peraman (ORCID: https://orcid.org/0000-0003-1932-637X)
- Debabrata Mandal (ORCID: https://orcid.org/0000-0001-6413-8509)
- Esha Bhargav
- Pragati Sinha
Institutions
- Ono Pharmaceutical (United States) (US)
- National Institute of Pharmaceutical Education and Research - Ahmedabad (IN)
- National Institute of Pharmaceutical Education and Research (IN)
- National Institute of Pharmaceutical Education and Research (IN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1080/03639045.2026.2613024
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00